Skip to main content

Table 2 MRI parameters according to groups with and without muscle invasion, for both readers (reader 1 top line; reader 2 bottom line)

From: What is the impact of dynamic contrast-enhancement sequence in the Vesical Imaging, Reporting and Data System (VI-RADS)? A subgroup analysis

  NMIBCa
n = 25
MIBCa
n = 25
p-value
Presence of stalk 4 (16.0%) 1 (4.0%) p = 0.16
4 (16.0%) 1 (4.0%) p = 0.16
Form papillary - 23 (92.0%)
flat - 2 (8.0%)
papillary - 16 (64.0%)
flat - 9 (36.0%)
p = 0.01
papillary - 23 (92.0%)
flat - 2 (8.0%)
papillary - 17 (68.0%)
flat - 9 (32.0%)
p = 0.03
Size (cm) 2.42 +/−  1.58
(0.7–7.0)
5.70+/−  2.67
(2.2–14.0)
p < 0.0001
2.37 +/−  1.50
(0.7–6.8)
5.44 +/−  2.90
(1.6–14.8)
p < 0.0001
  1. NMIBCa Non-muscle invasive bladder cancer, MIBCa Muscle-invasive bladder cancer, MRI Magnetic Resonance Imaging